Cover Image
市場調查報告書

亞太地區的非侵入式產前遺傳檢測(NIPT)市場預測

Asia Pacific NIPT Market Outlook 2018

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 312363
出版日期 內容資訊 英文 55 Pages
訂單完成後即時交付
價格
Back to Top
亞太地區的非侵入式產前遺傳檢測(NIPT)市場預測 Asia Pacific NIPT Market Outlook 2018
出版日期: 2014年09月01日 內容資訊: 英文 55 Pages
簡介

無侵入性產前遺傳檢測(NIPT)市場,在分子診斷市場上急速成長。亞太地區佔全球人口幾乎3分之一,潛在患者(高風險年齡層)約有200萬人,有20億美元以上的價值。

本報告提供亞太地區NIPT市場相關調查分析、檢驗概要、唐氏症的風險、各國市場潛在力、概要、規定方案等相關的系統性資訊。

第1章 分析師的見解

第2章 調查手法

第3章 簡介

第4章 胎兒唐氏症(DS)的風險與母親年齡之間的關聯

第5章 亞太地區的NIPT市場預測

  • 澳洲
    • 市場潛力
    • 市場概要
    • 法規方案
  • 中國
    • 市場潛在力
    • 市場概要
    • 法規方案
  • 日本
    • 市場潛在力
    • 市場概要
    • 法規方案
  • 印度
    • 市場潛在力
    • 法規方案

圖表

目錄

Non-Invasive Prenatal Testing (NIPT) has catapulted growth in the molecular diagnostics market. In the US, where the test was initially launched, the market is expected to grow at a CAGR of 49% during 2013-2018. However, owing to a restrictive potential population base in USA, which is estimated at around 700,000, companies based in the region have been quick to expand beyond their geography and launch the tests in the EU and selective regions of Asia-Pacific (APAC). For RNCOS' study, its experts have selected the APAC region since it represents a highly under penetrated market with immense potential for growth.

The APAC has almost one-third of the global population. According to RNCOS' report "Asia Pacific NIPT Market Outlook 2018", there are around 2 Million potential patients (high-risk age group) in the region, representing an over US$ 2 Billion worth potential market. The major market in this region lies in Japan, where the rapidly ageing population has created a huge, untapped potential market for the companies. China is another major region where two local players, BGI and Berry Genomics, are estimated to have collectively conducted around 100,000 tests in 2013 alone.

With the launch of a few NIPT tests, India represents a great opportunity for the growth of NIPT. The trend of pregnancies has witnessed a fundamental change in India in terms of the age of conceiving. Previously, the age group for pregnancy was usually 25 to 30 years. Now, it has increased to 28 to 35 years and above 35 years in some cases. This, therefore, augurs well for the growth of NIPT in India over the next few years. However, the growth can be marred by a lack of awareness of such tests and relatively lower affordability, with a major chunk of births taking place in the rural India.

RNCOS, in its report, covers an exhaustive analysis of the potential population for NIPT tests in the various regions. Different scenarios have also been explored in line with the regulatory environment in the different regions. Detailed description too has been provided of the current market scenario highlighting the currently available tests, business model followed by players, cost of their tests, number of tests accessioned by them, etc.

Besides, test volumes and markets till 2018 have been forecasted. These forecasts have been conducted on the basis of co-relation and judgmental analysis, which was carried out after carefully studying key factors, including rise in penetration, expansion in distributor network, rising popularity and awareness amongst consumers, regulatory scenario, and various other drivers and challenges.

Overall, the report presents optimum information and a transparent research outlook that highlights opportunities and potentials in the nascent APAC NIPT sector.

Table of Contents

1. Analyst View

2. Research Methodology

3. Introduction

  • 3.1 MaterniT21 PLUS
  • 3.2 Verifi
  • 3.3 Panorama
  • 3.4 Harmony
  • 3.5 NIFTY
  • 3.6 Bambni

4. Association of Down's syndrome Risk to Fetus with Mother's Age

5. Asia-Pacific NIPT Market Outlook to 2018

  • 5.1 Australia
    • 5.1.1 Market Potential
    • 5.1.2 Market Overview
    • 5.1.3 Regulatory Scenario
  • 5.2 China
    • 5.2.1 Market Potential
    • 5.2.2 Market Overview
    • 5.2.3 Regulatory Scenario
  • 5.3 Japan
    • 5.3.1 Market Potential
    • 5.3.2 Market Overview
    • 5.3.3 Regulatory Scenario
  • 5.4 India
    • 5.4.1 Market Potential
    • 5.4.2 Regulatory Scenario

List of Figures:

  • Figure 5-1: Australia - Number of Births ('000), 2012-2018
  • Figure 5-2: Australia - Number of Births by Mother's Risk of Down's syndrome (%), 2013
  • Figure 5-3: Australia - Potential Market in Three Different Scenarios (US$), 2013
  • Figure 5-4: Australia - NIPT Market (Million US$), 2013-2018
  • Figure 5-5: Australia - NIPT Market (Volume '000), 2013-2018
  • Figure 5-6: China - Number of Births (Million), 2012-2018
  • Figure 5-7: China - Number of Births by Mother's Risk of Down's syndrome (%), 2013
  • Figure 5-8: China - Potential Market in Two Different Scenarios (US$), 2013
  • Figure 5-9: China - NIPT Market (Million US$), 2013-2018
  • Figure 5-10: China - NIPT Market (Volume '000), 2013-2018
  • Figure 5-11: Japan - Number of Births ('000), 2012-2018
  • Figure 5-12: Japan - Number of Births by Mother's Risk of Down's syndrome (%), 2013
  • Figure 5-13: Japan - Potential Market in Two Different Scenarios (US$), 2013
  • Figure 5-14: Japan - NIPT Market (Million US$), 2013-2018
  • Figure 5-15: Japan - NIPT Market (Volume '00), 2013-2018
  • Figure 5-16: India - Number of Births (Million), 2012-2018
  • Figure 5-17: India - Number of Births by Mother's Risk of Down's syndrome (%), 2013
  • Figure 5-18: India - Potential Market in Two Different Scenarios (US$), 2013

List of Tables:

  • Table 3-1: Comparison of Features of Key NIPT Tests in APAC NIPT Market
  • Table 3-2: MaterniT21 PLUS Test Validation Results
  • Table 3-3: Verifi Test Validation Results
  • Table 3-4: Panorma Test Validation Results
  • Table 3-5: Harmony Test Validation Results
  • Table 3-6: NIFTY Test - Summary of Phase I Clinical Trial
  • Table 3-7: NIFTY Test - Summary of Phase II Clinical Trial
  • Table 3-8: Bambni Test - Summary of Phase I Clinical Trial
  • Table 3-9: Bambni Test - Summary of Phase II Clinical Trial
  • Table 4-1: Risk of Down's syndrome with Rise in Maternal Age
  • Table 5-1: Australia - Number of Births by Age of Mother (2012)
  • Table 5-2: Australia - Number of Births by Age of Mother (2013)
  • Table 5-3: Australia NIPT Market Landscape - Players; Australian Partner; Cost per Test
  • Table 5-4: China - Number of Births by Age of Mother (2012)
  • Table 5-5: China - Number of Births by Age of Mother (2013)
  • Table 5-6: China NIPT Market Landscape - Players; Cost per Test
  • Table 5-7: Japan - Number of Births by Age of Mother (2012)
  • Table 5-8: Japan - Number of Births by Age of Mother (2013)
  • Table 5-9: Japan NIPT Market Landscape - Player; Cost per Test
  • Table 5-10: India - Number of Births by Age of Mother (2000)
  • Table 5-11: India - India - Number of Births by Age of Mother (2013)
Back to Top